RecruitingACTRN12605000319673

Epidural Blood Patch - The Effect of Volume

Epidural Blood Patch - The Effect of Volume on efficacy- a Multi-National, Multi-Centre, Randomised Controlled Trial.


Sponsor

Professor Michael Paech, Professor of Obstetric Anaesthesia, School of Medicine and Pharmacology, University of Western Australia

Enrollment

120 participants

Start Date

Mar 1, 2004

Study Type

Interventional

Conditions

Summary

In this study we wish to work out what volume of blood, injected into the epidural area in an "epidural blood patch" best cures or helps treat headache caused by leak of spinal fluid. This leak occurs because a hole has been made in a membrane containing the spinal fluid, near the epidural space. An epidural blood patch is the only known way of stopping or effectively reducing headache of this type and is used worldwide to treat severe headaches of this type. It can fix the headache completely, but is often only partially effective. Many years ago the volume of blood used in an epidural blood patch was very small. Later the recommended volume was increased to about 15 ml, as this appeared to work better. Subsequently, larger volumes of blood, such as 20 ml, were recommended, while some anaesthetists now claim best results when even more is injected. There have not been any well controlled studies comparing different volumes of blood for epidural blood patch. Although larger volumes of blood are currently favoured, these may be associated with a higher incidence of mild or moderate low back pain during the injection and subsequent back soreness. A number of maternity units in Australasia and overseas will be involved in this study and the results will be of interest internationally. What does the study involve? The epidural blood patch will be performed in the usual way. Patients will be randomised to one of three groups, each group receiving a slightly different volume of blood (15 ml, 20 ml or the maximum volume up to 30 ml that can be injected without causing significant discomfort in the back). It is usually easy to inject 15 or 20 ml without causing significant back discomfort and the volumes chosen are all ones commonly used by maternity units around the world. In addition, to make sure the most accurate results are obtained, neither the patient or the staff asking questions about well-being after the epidural blood patch will know which group the patient was in. Patients will be asked questions about the severity and characteristics of the headache both before and at regular intervals after the epidural blood patch (at 2, 4, 24, 48, 72 hours and 5 days, by telephone if the patient has left hospital). Patients will also be asked about back discomfort experienced during and after the procedure, and whether they noticed any effects other than relief of the headache. As is usual practice, patients will be rested flat in bed for 2 hours after the epidural blood patch and then be allowed to get up, according to the usual practice in the hospital. If the patient does not get complete relief of the headache or suffers a return of headache later, they will be able to use a variety of drugs to try and get some relief. Also, if necessary, another blood patch could be performed, once more than 48 hours has passed from the first epidural blood patch. We will not know whether any particular volume is more effective than another. With an epidural blood patch, a common effect is mild back discomfort during injection and for a variable time after the blood patch, lasting up to a few days. If the patient experiences significant back pain during the injection, the injection will be stopped according to usual practice, irrespective of whether they have received the amount for their group. Usually back pain during injection is mild and easy to handle. Most women describe back stiffness rather than pain after the epidural blood patch. It has been suggested that injection of the largest volume of blood may be more effective but also cause more back discomfort, but this has not been confirmed by proper study. There are some very rare serious complications of epidural blood patch, such as infection, severe back pain and blood clots around the brain, but there is no suggestion that taking part in the study is likely to affect the risk of these in any way.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study is looking at whether the amount of blood used in an epidural blood patch makes a difference to how well it treats a severe headache caused by a spinal fluid leak. This type of headache (called PDPH — post-dural puncture headache) can happen after an epidural procedure where a needle accidentally makes a small hole in the membrane around the spinal cord. An epidural blood patch, where a small amount of the patient's own blood is injected near the spinal area, is the standard treatment. Researchers are comparing three different volumes of blood (15 ml, 20 ml, or up to 30 ml) to see which works best. You may be eligible if: - You are a pregnant patient who has developed a severe postural headache (worse when standing, better when lying down) after an unintentional dural puncture during an epidural - You are medically suitable for an epidural blood patch - You are 18 years of age or older You may NOT be eligible if: - You have already had an epidural blood patch for this headache - Your blood patch is scheduled to happen less than 24 hours or more than 5 days after the dural puncture - You had significant back or leg pain during pregnancy that required treatment - Your headache turns out to have a different cause Talk to your doctor about whether this trial might be right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

This multinational, multi-centre, randomised controlled trial is to address the question: "What is the volume of blood for injection at epidural blood patch that most effectively relieves post-dural p

This multinational, multi-centre, randomised controlled trial is to address the question: "What is the volume of blood for injection at epidural blood patch that most effectively relieves post-dural puncture headache?" The volume of blood empirically recommended for epidural blood patch (EBP) has increased from 2-3 ml at its first description in the 1960s, to 10 ml during 1970-90, to 15-20 ml in the 1990s. Currently, some obstetric anaesthetists advocate the maximum amount tolerated by the patient before back discomfort limits further injection. The study will randomise pregnant or early postpartum women who have headache secondary to inadvertent dural puncture with an epidural needle to one of three groups, to receive 15 ml, 20 ml or the maximum tolerated volume of blood (maximum 30 ml). The primary endpoint is the partial success rate of EBP, that is, >50% reduction in headache severity after 4 hours or complete relief of headache at 4 hours but return of postural headache subsequently. The secondary endpoint is the complete success rate (that is the complete relief of headache at 4 hours and thereafter, with no recurrence of headache). Blood patching is the "gold standard" therapy for headache due to low intracranial pressure or following inadvertent or deliberate dural puncture. The significance of this project is that there is no scientific evidence on which to base the choice of volume of injected blood for EBP. Larger volumes of blood are currently favoured, but may be associated with a higher incidence of patient pain during injection (higher epidural and subarachnoid space pressure) and subsequent back soreness. The results would be relevant internationally.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12605000319673